Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-12

Clinical Trial Update: Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL [NA]

View source ↗

Summary

This document reports a status update for a bicentric clinical investigation of LuxBoost IOL to assess its safety and performance in aphakia; the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LuxBoost IOL

Snippet

Sponsor: Cutting Edge SAS | Conditions: Aphakia | NA | Status: RECRUITING